Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer

Surgery (United States)

Volumn 158, Issue 4, 2015, Pages 981-987

  Batchu, Ramesh B ^a,b,c   Gruzdyn, Oksana V ^a,b   Qazi, Aamer M ^a,b   Kaur, Jaskiran ^a   Mahmud, Ebrahem M ^a   Weaver, Donald W ^a   Gruber, Scott A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Virocan Therapeutics Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; K RAS PROTEIN; MICRORNA 26A; PROTEIN P53; MICRORNA; MIRN26A MICRORNA, HUMAN; TUMOR MARKER;

APOPTOSIS; ARTICLE; ASSAY; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHEMOSENSITIVITY; COLONY FORMATION; CONTROLLED STUDY; DRUG RETENTION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTANT; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WILD TYPE; CANCER STEM CELL; CELL CYCLE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MUTATION; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84940770753     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.05.019     Document Type: Article

References (26)

1. M.S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi, and G.A. Calin MicroRNAs - the micro steering wheel of tumour metastases Nat Rev Cancer 9 2009 293 302
2. J. Kota, R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, H.W. Hwang, and et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 2009 1005 1017
3. M. Lv, X. Zhang, M. Li, Q. Chen, M. Ye, W. Liang, and et al. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma PLoS One 8 2013 e67591
4. N.M. Alajez, W. Shi, A.B. Hui, J. Bruce, M. Lenarduzzi, E. Ito, and et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98 Cell Death Dis 1 2010 e85
5. P. Liu, H. Tang, B. Chen, Z. He, M. Deng, M. Wu, and et al. miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer Cancer Lett 357 2015 384 392
6. P. Guo, Q. Nie, J. Lan, J. Ge, Y. Qiu, and Q. Mao C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells Biochem Biophys Res Commun 441 2013 186 190
7. B. Liu, X. Wu, B. Liu, C. Wang, Y. Liu, Q. Zhou, and et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN Biochim Biophys Acta 1822 2012 1692 1704
8. E.J. Lee, Y. Gusev, J. Jiang, G.J. Nuovo, M.R. Lerner, W.L. Frankel, and et al. Expression profiling identifies microRNA signature in pancreatic cancer Int J Cancer 120 2007 1046 1054
9. M. Bloomston, W.L. Frankel, F. Petrocca, S. Volinia, H. Alder, J.P. Hagan, and et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 297 2007 1901 1908
10. E.L. Deer, J. Gonzalez-Hernandez, J.D. Coursen, J.E. Shea, J. Ngatia, C.L. Scaife, and et al. Phenotype and genotype of pancreatic cancer cell lines Pancreas 39 2010 425 435
11. G. Berrozpe, J. Schaeffer, M.A. Peinado, F.X. Real, and M. Perucho Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer Int J Cancer 58 1994 185 191
12. P.S. Moore, S. Beghelli, G. Zamboni, and A. Scarpa Genetic abnormalities in pancreatic cancer Mol Cancer 2 2003 7
13. E. Beurel, M. Kornprobst, M.J. Blivet-Van Eggelpoel, C. Ruiz-Ruiz, A. Cadoret, J. Capeau, and et al. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression Exp Cell Res 300 2004 354 364
14. Y. Higashimoto, S. Saito, X.H. Tong, A. Hong, K. Sakaguchi, E. Appella, and et al. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents J Biol Chem 275 2000 23199 23203
15. Y. Wang, and C. Prives Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases Nature 376 1995 88 91
16. T. Unger, R.V. Sionov, E. Moallem, C.L. Yee, P.M. Howley, M. Oren, and et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity Oncogene 18 1999 3205 3212
17. W. Li, Y. Yuan, L. Huang, M. Qiao, and Y. Zhang Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells Diabet Res Clin Pract 96 2012 187 195
18. J. Deng, M. He, L. Chen, C. Chen, J. Zheng, and Z. Cai The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival PLoS One 8 2013 e76450
19. S. Rejiba, C. Bigand, C. Parmentier, and A. Hajri Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies Neoplasia 11 2009 637 650
20. R. Brosh, and V. Rotter When mutants gain new powers: news from the mutant p53 field Nat Rev Cancer 9 2009 701 713
21. C.J. Sherr Principles of tumor suppression Cell 116 2004 235 246
22. K. Okaichi, K. Nose, T. Kotake, N. Izumi, and T. Kudo Phosphorylation of p53 modifies sensitivity to ionizing radiation Anticancer Res 31 2011 2255 2258
23. B. Fuchs, D. O'Connor, L. Fallis, K.H. Scheidtmann, and X. Lu p53 phosphorylation mutants retain transcription activity Oncogene 10 1995 789 793
24. K. Sakaguchi, H. Sakamoto, M.S. Lewis, C.W. Anderson, J.W. Erickson, E. Appella, and et al. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53 Biochemistry 36 1997 10117 10124
25. M. Cordenonsi, M. Montagner, M. Adorno, L. Zacchigna, G. Martello, A. Mamidi, and et al. Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation Science 315 2007 840 843
26. P.R. Konkalmatt, D. Deng, S. Thomas, M.T. Wu, C.D. Logsdon, B.A. French, and et al. Plectin-1 targeted AAV vector for the molecular imaging of pancreatic cancer Front Oncol 3 2013 84